What is ICR's earnings per share (EPS)?

ICR (ICR) reported diluted earnings per share of -$0.75 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ICR Financials

ICR

Trailing 12 months to March 31, 2026

Revenue $22.4M -8.8% YoY

Net Income -$9.7M -173.1% YoY

EPS (Diluted) -$0.75 FY2025 annual

Operating Cash Flow $10.5M -36.7% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 8, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ICR SEC filings page.

ICR (ICR) reported $22.4M in revenue over the twelve months to Mar 31, 2026, down 8.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ICR FY2025 2026-08-29

Balance-sheet contraction is ICR’s dominant mechanic: shrinking liabilities and assets matter more than its thin, volatile earnings.

The earnings-to-cash relationship is unusually disconnected: FY2025 produced a net loss of $1.6M but operating cash flow of $11.4M, while FY2024’s $12.7M profit converted to $18.0M. Repeated positive cash generation amid sharply changing profit suggests non-cash or timing items materially influence reported earnings, making accounting profitability an incomplete view of operations.

From FY2023 to FY2025, liabilities fell 42.8% while assets fell 32.2%. That balance-sheet asymmetry, with equity comparatively stable and debt-to-equity declining from 2.1x to 1.3x, indicates deleveraging through contraction rather than expansion funded by new equity.

FY2025’s investing cash flow was $136.3M against financing cash flow of -$133.2M, a near-offset consistent with assets being converted into cash while financing outflows were paid. Dividends remained about $12.6M even as net income turned negative, showing distributions were not tightly linked to that year’s accounting profit.

Financial Health Signals

Financial health score not available

ICR does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/5

ICR passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

ICR reported a net loss of $1.6M while generating $11.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.2M

YoY-10.6%

QoQ-14.7%

5Y CAGR-1.0%

ICR generated $5.2M in revenue in Q1 2026. This represents a decrease of 10.6% from the same quarter a year earlier. Against the prior quarter it is down 14.7%.

Net Income

-$4.1M

YoY-204.9%

QoQ-334.3%

ICR reported -$4.1M in net income in Q1 2026. This represents a decrease of 204.9% from the same quarter a year earlier. Against the prior quarter it is down 334.3%.

EPS (Diluted)

-$0.56

ICR earned -$0.56 per diluted share (EPS) in Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$80.0M

YoY+35.3%

QoQ+4.5%

5Y CAGR+8.7%

ICR held $80.0M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

Diluted avg 10M

ICR had a weighted average of 10M diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin

-80.1%

YoY-148.3pp

QoQ-64.4pp

5Y change-105.3pp

ICR's net profit margin was -80.1% in Q1 2026, showing the share of revenue converted to profit. This is down 148.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 64.4 percentage points.

Return on Equity

-1.9%

YoY-3.5pp

QoQ-1.5pp

5Y change-2.5pp

ICR's ROE was -1.9% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

ICR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ICR quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$22.4M	$23.0M-5.7%	$24.4M-37.1%	$38.8M+1.9%	$38.0M+34.5%	$28.3M+17.2%	$24.1M+19.2%	$20.3M+188.8%	$7.0M	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$3.7M+3732.3%	$96K
Interest Expense	$21.7M	$24.0M-34.4%	$36.5M-13.5%	$42.2M+97.4%	$21.4M+142.8%	$8.8M-14.7%	$10.3M-26.5%	$14.0M+243.1%	$4.1M+2522.4%	$156K
Income Tax	N/A	$0	$0-100.0%	$22K	$0	$0	N/A	$0+100.0%	-$13K-122.4%	$58K
Net Income	-$9.7M	-$1.6M-112.4%	$12.7M+385.5%	-$4.4M-143.6%	$10.2M+3.1%	$9.9M+134.3%	-$28.8M-310.0%	$13.7M+562.4%	$2.1M+2454.3%	$81K
EPS (Basic)	N/A	-$0.75-213.6%	$0.66+164.1%	-$1.03-345.2%	$0.42-41.7%	$0.72+128.9%	-$2.49	N/A	N/A	N/A
EPS (Diluted)	—	-$0.75	$0.66	-$1.03	$0.42	$0.72+128.9%	-$2.49	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	10M	10M	10M	11M	11M-0.7%	12M+29.1%	9M+146.2%	4M	757,025

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$5.2M-10.6%	$6.1M-7.8%	$5.2M-20.2%	$5.9M+5.3%	$5.8M+2.7%	$6.6M+6.3%	$6.5M-41.0%	$5.6M-52.9%
Interest Expense	$4.5M-33.1%	$5.1M-37.5%	$5.6M-40.8%	$6.4M-31.4%	$6.8M-28.2%	$8.2M-21.7%	$9.5M-12.2%	$9.4M-12.6%
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%
Net Income	-$4.1M-204.9%	-$954K-126.0%	-$7.6M-1342.4%	$3.1M-38.4%	$3.9M+16.2%	$3.7M+185.4%	$615K-87.7%	$5.0M+132.5%
EPS (Basic)	-$0.56-333.3%	N/A	-$0.90-900.0%	$0.16-54.3%	$0.24+26.3%	N/A	-$0.09-125.7%	$0.35+121.1%
EPS (Diluted)	-$0.56	N/A	-$0.90-900.0%	$0.16-54.3%	$0.24+26.3%	N/A	-$0.09-125.7%	$0.35
Diluted Shares (Avg)	10M	N/A	10M0.0%	10M0.0%	10M0.0%	N/A	10M0.0%	10M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

ICR Balance Sheet

ICR quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Total Assets	$529.2M-20.0%	$661.3M-15.3%	$780.3M-14.7%	$914.5M+19.6%	$764.4M+37.7%	$555.0M-21.1%	$703.3M+89.1%	$372.0M+508.5%	$61.1M
Cash & Equivalents	$76.6M+18.6%	$64.5M+19.2%	$54.1M+84.1%	$29.4M-48.6%	$57.3M-20.6%	$72.1M+93.8%	$37.2M+35.2%	$27.5M+1999.9%	$1.3M
Total Liabilities	$303.0M-27.3%	$416.7M-21.3%	$529.8M-16.7%	$635.9M+39.1%	$457.3M+45.3%	$314.7M-29.6%	$447.2M+94.6%	$229.8M+1099.3%	$19.2M
Total Equity	$226.2M-7.5%	$244.6M-2.4%	$250.6M-10.1%	$278.6M-9.3%	$307.1M+27.8%	$240.3M-6.2%	$256.2M+80.1%	$142.3M+238.9%	$42.0M
Retained Earnings	-$115.1M-21.2%	-$95.0M-6.6%	-$89.0M-46.1%	-$60.9M-16.6%	-$52.3M-10.6%	-$47.3M-381.8%	-$9.8M-53.6%	-$6.4M-341.8%	-$1.4M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$513.4M-21.9%	$529.2M-20.0%	$552.8M-24.1%	$616.4M-16.0%	$657.2M-13.1%	$661.3M-15.3%	$727.9M-10.1%	$734.2M-14.1%
Cash & Equivalents	$80.0M+35.3%	$76.6M+18.6%	$70.9M+20.5%	$27.0M-39.3%	$59.1M-2.1%	$64.5M+19.2%	$58.8M+9.6%	$44.6M-0.2%
Total Liabilities	$295.9M-28.4%	$303.0M-27.3%	$321.7M-33.3%	$373.0M-23.0%	$413.3M-18.5%	$416.7M-21.3%	$482.3M-13.2%	$484.6M-19.3%
Total Equity	$217.5M-10.8%	$226.2M-7.5%	$231.1M-5.9%	$243.3M-2.5%	$243.9M-2.2%	$244.6M-2.4%	$245.6M-3.3%	$249.6M-1.6%
Retained Earnings	-$123.9M-29.5%	-$115.1M-21.2%	-$109.5M-16.5%	-$97.2M-8.1%	-$95.7M-5.9%	-$95.0M-6.6%	-$94.0M-9.7%	-$89.9M-4.6%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

ICR Cash Flow Statement

ICR quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Operating Cash Flow	$10.5M	$11.4M-36.6%	$18.0M+11.0%	$16.2M-12.5%	$18.5M+59.0%	$11.6M-3.0%	$12.0M+19.1%	$10.1M+212.2%	$3.2M+951.5%	$307K
Depreciation & Amortization	N/A	$5.4M+253.8%	$1.5M+197.1%	$514K-54.5%	$1.1M+3.8%	$1.1M+168.9%	$405K	N/A	N/A	N/A
Investing Cash Flow	$150.9M	$136.3M+6.9%	$127.6M+32.2%	$96.5M+153.5%	-$180.6M+18.8%	-$222.4M-235.7%	$163.9M+151.6%	-$317.6M-12.2%	-$283.1M-436.4%	-$52.8M
Financing Cash Flow	-$137.9M	-$133.2M+1.5%	-$135.2M-53.6%	-$88.0M-165.6%	$134.2M-31.5%	$195.9M+238.5%	-$141.5M-144.7%	$316.6M+3.2%	$307.0M+475.2%	$53.4M
Dividends Paid	$12.6M	$12.6M0.0%	$12.6M+0.7%	$12.5M+0.5%	$12.4M+0.5%	$12.4M+33.9%	$9.3M-43.4%	$16.3M+158.2%	$6.3M+411.4%	$1.2M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$22.4M+56.0%	$14.3M+1778.8%	$763K-60.1%	$1.9M+4054.3%	$46K	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$2.0M-30.3%	$2.5M-46.3%	$2.9M-47.9%	$3.2M-13.5%	$2.8M-32.1%	$4.6M+18.2%	$5.5M-8.3%	$3.8M-27.1%
Depreciation & Amortization	$1.2M+28.6%	$1.4M+57.2%	$1.8M+178.0%	$1.3M	$928K	$871K	$656K	$0-100.0%
Investing Cash Flow	$13.8M+2011.9%	$25.1M-65.0%	$100.6M+470.5%	$11.4M+21.1%	-$723K-102.5%	$71.8M+175.4%	$17.6M+3.2%	$9.4M-70.8%
Financing Cash Flow	-$12.3M-63.0%	-$22.3M+68.4%	-$56.6M-539.5%	-$46.7M-61.2%	-$7.5M+71.8%	-$70.6M-139.8%	-$8.8M+36.9%	-$29.0M-133.1%
Dividends Paid	$3.2M0.0%	$3.2M0.0%	$3.2M0.0%	$3.1M0.0%	$3.2M+0.1%	$3.2M0.0%	$3.2M+0.1%	$3.1M+0.1%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

ICR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ICR quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Net Margin	-6.8%-58.8pp	51.9%+63.4pp	-11.4%-38.2pp	26.8%-8.1pp	34.9%	-119.2%	67.7%+38.2pp	29.5%	N/A
Return on Equity	-0.7%-5.9pp	5.2%+7.0pp	-1.8%-5.4pp	3.6%+0.4pp	3.2%+15.2pp	-12.0%-17.3pp	5.3%+3.9pp	1.5%+1.3pp	0.2%
Return on Assets	-0.3%-2.2pp	1.9%+2.5pp	-0.6%-1.7pp	1.1%-0.2pp	1.3%+6.5pp	-5.2%-7.1pp	1.9%+1.4pp	0.6%+0.4pp	0.1%
Debt-to-Equity	1.34-0.4x	1.70-0.4x	2.11-0.2x	2.28+0.8x	1.49+0.2x	1.31-0.4x	1.75+0.1x	1.61+1.2x	0.46
Asset Turnover	0.040.0x	0.040.0x	0.050.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.02	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	-80.1%-148.3pp	-15.7%-71.5pp	-146.1%	51.8%-36.8pp	68.2%+7.9pp	55.7%+35.0pp	9.4%-35.6pp	88.7%
Return on Equity	-1.9%-3.5pp	-0.4%-1.9pp	-3.3%-3.6pp	1.3%-0.7pp	1.6%+0.3pp	1.5%+1.0pp	0.3%-1.7pp	2.0%+8.1pp
Return on Assets	-0.8%-1.4pp	-0.2%-0.7pp	-1.4%-1.5pp	0.5%-0.2pp	0.6%+0.2pp	0.5%+0.4pp	0.1%-0.5pp	0.7%+2.5pp
Debt-to-Equity	1.36-0.3x	1.34-0.4x	1.39-0.6x	1.53-0.4x	1.69-0.3x	1.70-0.4x	1.96-0.2x	1.94-0.4x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Where ICR Ranks

Frequently Asked Questions

What is ICR's annual revenue?

ICR (ICR) reported $23.0M in total revenue for fiscal year 2025. This represents a -5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ICR's revenue growing?

ICR (ICR) revenue declined by 5.7% year-over-year, from $24.4M to $23.0M in fiscal year 2025.

Is ICR profitable?

No, ICR (ICR) reported a net income of -$1.6M in fiscal year 2025, with a net profit margin of -6.8%.

What is ICR's net profit margin?

ICR (ICR) had a net profit margin of -6.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ICR's return on equity (ROE)?

ICR (ICR) has a return on equity of -0.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ICR's operating cash flow?

ICR (ICR) generated $11.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ICR's total assets?

ICR (ICR) had $529.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What is ICR's debt-to-equity ratio?

ICR (ICR) had a debt-to-equity ratio of 1.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ICR's return on assets (ROA)?

ICR (ICR) had a return on assets of -0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ICR's Piotroski F-Score?

ICR (ICR) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ICR's earnings high quality?

ICR (ICR) reported a net loss of $1.6M while generating $11.4M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.